Home

Jeffrey B. Mirviss

CIK 1566094 · EVP&Pres, Periph Intervent · last filed 2026-07-02

Jeffrey B. Mirviss is an EVP&Pres, Periph Intervent who has filed 131 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for CNMD, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$32.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.56M

Companies

2

Total Filings

131

Lifetime Open-Market Net

-$32.16M

Filer Profile

Reported Address
C/O BOSTON SCIENTIFIC CORPORATION
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CNMD Director — $49.32 — $0 1 2026-07-02
BSX EVP&Pres, Periph Intervent 53,454 $47.80 $2.56M -$32.16M 117 2025-02-25

Recent Filings

131 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-02 CNMD Grant (A) — $0 EDGAR
2025-02-25 BSX Notice (144) −2,688 -$279.6K EDGAR
2025-02-25 BSX Sell (S) −7,363 -$766.9K EDGAR
2025-02-24 BSX Notice (144) −4,675 -$487.4K EDGAR
2025-02-19 BSX Notice (144) −1,510 -$159.1K EDGAR
2025-02-19 BSX Sell (S) −1,510 -$159.1K EDGAR
2025-02-18 BSX Mixed +4,938 -$439.5K EDGAR
2025-02-14 BSX Mixed +1,247 -$91.8K EDGAR
2025-02-13 BSX Mixed — -$2.51M EDGAR
2025-02-12 BSX Notice (144) −13,022 -$1.37M EDGAR
Showing 1–10 of 131
Page 1 of 14
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.